What is the sentiment of this news? Please choose an answer from {strong negative/moderately negative/mildly negative/neutral/mildly positive/moderately positive/strong positive}.

Amgen Inc. (NASDAQ:AMGN ) Q1 2022 Results Conference Call April 27, 2022 5:00 PM ET Company Participants Arvind Sood - VP, IR Bob Bradway - Chairman and CEO Peter Griffith - CFO Murdo Gordon - EVP, Global Commercial Operations David Reese - EVP, Research and Development Conference Call Participants Michael Yee - Jefferies Jay Olson - Oppenheimer Goeff Meacham - Bank of America Salveen Richter - Goldman Sachs Matthew Harrison - Morgan Stanley Yaron Werber - Cowen & Company Umer Raffat - Evercore ISI Carter Gould - Barclays Robyn Karnauskas - Truist Mohit Bansal - Wells Fargo Dane Leone - Raymond James Evan Seigerman - BMO Capital Markets Gavin Scott - JPMorgan Colin Bristow - UBS Operator My name is RJ, and I will be your conference facilitator today for Amgen's First Quarter 2022 Financial Results Conference Call. All lines have been placed on mute to prevent any background nose.
neutral